DOW JONES28,949.70-270.28 -0.93%
S&P 5003,332.20-41.03 -1.22%
NASDAQ9,556.39-194.57 -2.00%

Wells Fargo Maintains Equal-Weight on Biogen, Raises Price Target to $311

Wells Fargo maintains Biogen (NASDAQ:BIIB) with a Equal-Weight and raises the price target from $286 to $311.

Benzinga · 02/06/2020 12:54

Wells Fargo maintains Biogen (NASDAQ:BIIB) with a Equal-Weight and raises the price target from $286 to $311.